Osteoporosis in primary biliary cirrhosis revisited

BACKGROUND Primary biliary cirrhosis (PBC) is increasingly being diagnosed in the earlier non-cholestatic stages of disease. Accepted wisdom has been that PBC is frequently complicated by osteoporosis. Whether this association holds true for the broader spectrum of PBC patients now recognised has not as yet been studied. AIMS To examine the extent to which osteoporosis occurs more commonly in PBC patients than in normal individuals of the same age and sex. DESIGN Retrospective review of a large cohort of well characterised PBC patients. PATIENTS A total of 272 PBC patients with definite or probable PBC followed up for a mean of 10.1 years (total follow up 2726 patient years) who had at least one bone mineral density measurement (BMD). RESULTS In this unselected group of PBC patients, mean Z scores (number of SDs from age and sex matched normal mean values) at the neck of femur (NOF) and lumbar spine (LS) at first BMD measurement (7 (6) years after PBC diagnosis) were −0.1 (1.4) and 0.1 (1.4), respectively. At first BMD measurement, 18 PBC patients had Z scores less than −2.0 and 85 had T scores less than −2.5. No factors predictive of osteoporosis were found in affected patients. A total of 957 BMD measurements were performed (0.35 per patient year of follow up); 220 patients had two or more measurements. No patient went on to develop de novo osteoporosis during follow up. In the 51 patients (who were clinically representative of the whole group) who received no PBC or bone related treatment during follow up, %BMD changes per year at the NOF and LS were −1.6 (3.2) and 0.1 (2.2), respectively. No variance in this “natural” rate of BMD measurement was seen in patients receiving PBC modulating agents (including prednisolone and UDCA) or osteoporosis prophylaxis/therapy. Significant improvement at the LS was seen in patients undergoing liver transplantation. CONCLUSIONS Osteoporosis is not a specific complication of PBC.

[1]  J. Newton,et al.  Presentation and mortality of primary biliary cirrhosis in older patients. , 2000, Age and ageing.

[2]  David C. Jones,et al.  Primary biliary cirrhosis: clinical and associated autoimmune features and natural history. , 1998, Clinics in liver disease.

[3]  K. Lindor,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.

[4]  R. Bhopal,et al.  Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. , 1997, International journal of epidemiology.

[5]  R. Bhopal,et al.  Primary biliary cirrhosis: epidemiology helping the clinician , 1996, BMJ.

[6]  R. Francis,et al.  Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. , 1996, Bone.

[7]  E. Dickson,et al.  Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. , 1995, The Journal of clinical investigation.

[8]  Claus Christiansen,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. , 1994, World Health Organization technical report series.

[9]  E. Dickson,et al.  Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis , 1991, Hepatology.

[10]  P. Lindgreen,et al.  Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis , 1989, Journal of internal medicine.

[11]  M. Bassendine,et al.  Metabolic bone disease in primary biliary cirrhosis at presentation. , 1988, Gastroenterology.

[12]  K. Mann,et al.  Bone loss and reduced osteoblast function in primary biliary cirrhosis. , 1985, Annals of internal medicine.

[13]  J. Compston,et al.  Osteoporosis in chronic cholestatic liver disease. , 1985, The Quarterly journal of medicine.

[14]  M. Kaplan,et al.  Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. , 1982, Gastroenterology.

[15]  S. Sherlock,et al.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis. , 1973, The New England journal of medicine.

[16]  S. Sherlock,et al.  Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. , 1968, Lancet.

[17]  B. Nordin,et al.  Malabsorption and bone disease in prolonged obstructive jaundice. , 1956, The Quarterly journal of medicine.